Attovia Therapeutics
Fremont, CA
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.
attovia.comCompany Details
Founded
- 2023
Employees
- Between 20 - 50 employees
Raised
- $255,000,000
Headquarters Location
- Fremont, CA
Public
- No
Acquired
- No
CEO
Tao Fu
Founders
- David KingTao Fu
Company Collections
These are collections Attovia Therapeutics is a part of. Click on the collection name to view similar companies.
Attovia Therapeutics' Industries
Attovia Therapeutics Headquarters Location
Fremont, CA 94538
Total Amount Raised: $255,000,000
Attovia Therapeutics Funding Rounds
Series C
$90,000,000
Series C Investors
Deep Track CapitalvenBio PartnersEcoR1 CapitalSanofiVida VenturesCormorant Asset ManagementMirae Asset Capital Life ScienceMarshall WaceNextech VenturesGoldman Sachs Asset ManagementIllumina VenturesFrazier Life SciencesSeries B
$105,000,000
Series B Investors
Goldman Sachs Asset ManagementCormorant Asset ManagementFrazier Life SciencesIllumina VenturesvenBio PartnersLogos CapitalEcoR1 CapitalNextech VenturesRedmile GroupMarshall WaceSeries A
$60,000,000
Series A Investors
Frazier Life SciencesIllumina VenturesvenBio Partners
Funding info provided by Diffbot.
Attovia Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Attovia Therapeutics.